Harpoon Therapeutics and its corporate directors were hit with a securities lawsuit on Feb. 13 in Delaware District Court in connection with a proposed acquisition by Merck Sharp & Dohme. The case, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results